PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION

Wolf, 1978, Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study, Neurology, 28, 973, 10.1212/WNL.28.10.973

Wolf, 1983, Duration of atrial fibrillation and imminence of stroke: The Framingham study, Stroke, 14, 664, 10.1161/01.STR.14.5.664

Boysen, 1988, Stroke incidence and risk factors for stroke in Copenhagen, Denmark, Stroke, 19, 1345, 10.1161/01.STR.19.11.1345

Petersen, 1987, Silent cerebral infarction in chronic atrial fibrillation, Stroke, 18, 1098, 10.1161/01.STR.18.6.1098

Petersen, 1986, Embolic complications in paroxysmal atrial fibrillation, Stroke, 17, 622, 10.1161/01.STR.17.4.622

Treseder, 1986, Atrial fibrillation and stroke in elderly hospitalized patients, Age Ageing, 15, 89, 10.1093/ageing/15.2.89

Kopecky, 1987, The natural history of lone atrial fibrillation A population based study over three decades, N Engl J Med, 317, 669, 10.1056/NEJM198709103171104

Selzer, 1982, Atrial fibrillation revisited, N Engl J Med, 306, 1044, 10.1056/NEJM198204293061709

Godtfredsen, 1975

Poller, 1985, Therapeutic ranges in anticoagulant administration, Br Med J, 290, 1683, 10.1136/bmj.290.6483.1683

O'Brien, 1979, A multiple testing procedure for clinical trials, Biometrics, 35, 549, 10.2307/2530245

P. Petersen, J. Godtfredsen, Atrial fibrillation—a review of course and prognosis.

1984, Acta Med Scand, 216, 5

Bucknall, 1986, Physicians' attitudes to four common problems: hypertension, atrial fibrillation, transient ischaemic attacks, and angina pectoris, Br Med J, 293, 739, 10.1136/bmj.293.6549.739

Szekely, 1964, Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease, Br Med J, i, 1209, 10.1136/bmj.1.5392.1209

Flemming, 1971, Mitral valve disease, systemic embolism and anticoagulants, Postgrad Med J, 47, 599, 10.1136/pgmj.47.551.599

Roy, 1986, Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation, Am Heart J, 112, 1039, 10.1016/0002-8703(86)90318-2

Schwartz, 1967, Explanatory and pragmatic attitudes in therapeutic trials, J Chron Dis, 26, 637, 10.1016/0021-9681(67)90041-0

Levine, 1986, Hemorrhagic complications of long-term anticoagulant therapy for ,ischemic cerebral vascular disease, Stroke, 17, 111, 10.1161/01.STR.17.1.111

Wintzen, 1984, The risk of intracerebral hemorrhage during oral anticoagulant treatment: A population study, Ann Neurol, 16, 553, 10.1002/ana.410160505

Peto, 1988, Randomised trial of prophylactic daily aspirin in British male doctors, Br Med J, 296, 313, 10.1136/bmj.296.6618.313

Relman, 1988, Aspirin for the primary prevention of myocardial infarction, N Engl J Med, 318, 245, 10.1056/NEJM198801283180410

Waldemar, 1988, Inhibition of platelet function by low-dose plain and micro-encapsulated acetylsalicylic acid, Thromb Res, 50, 265, 10.1016/0049-3848(88)90227-7